VONTOBEL FINANCIAL PRODUCTS LTD. | Market Closed - Swiss Exchange 11:20:00 2024-06-28 EDT | ||
| 61.8 USD | +1.64% |
|
| Current month | -2.06% | ||
| 1 month | -1.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 61.8 | +1.64% |
| 24-06-27 | 60.8 | -1.62% |
| 24-06-26 | 61.8 | -0.80% |
| 24-06-25 | 62.3 | +0.97% |
| 24-06-24 | 61.7 | +0.82% |
Delayed Quote Swiss Exchange
Last update June 28, 2024 at 11:20 am
More quotesStatic data
| Product type | Discount-Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Vontobel
|
| DPFAAV | |
| ISIN | CH1233987291 |
| Date issued | 2023-01-19 |
| Maturity | 2024-07-19 (19 Days) |
| Parity | 0.05 : 1 |
| Emission price | 83.5 $ |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | USD |
Technical Indicators
| Highest since issue | 83 $ |
|---|---|
| Lowest since issue | 55.2 $ |
| Spread | 4 $ |
| Spread % | 0.64% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.98
USD
Average target price
31.92
USD
Spread / Average Target
+14.07%
- Stock Market
- Certificates
- DPFAAV Certificat
